logo
← ETF screener

First Trust NYSE Arca Biotechnology UCITS ETF

FBTU.L

First Trust

First Trust NYSE Arca Biotechnology UCITS ETF (FBTU.L) on the Akinda fund screen (AAOIFI-derived): Not halal. Coverage 99.90%. Below: the fund under all five rulebooks, its facts and every holding with its own verdict.

Akinda fund screen

Akinda fund screen (AAOIFI-derived)Not halalCoverage: 99.90%
  • Halal 82.83%
  • Doubtful 0.00%
  • Not halal 17.07%
  • Not rated 0.10%

The bar is scaled to fit; the figures are as reported, and the buckets do not always total 100%.

Coverage is the share of the fund's weight we hold a usable verdict for. Below 95%, a fund is rated only when the weight we can see already breaches the 5% limit; otherwise it is not rated by this method.

Fund facts

Issuer
First Trust
Venue (where it trades)
United Kingdom
Domicile (where it is registered)
Ireland
Reporting currency
USD
Expense ratio
0.60%
AUM
18.76M USD
Holdings
30 (30 screened)
Basket as of (provider)
30 Oct 2026
Basket fetched by Akinda
30 Oct 2026
Verdict updated
3 Nov 2026

Venue is where a fund trades; domicile is where it is registered. London-listed funds are domiciled in Ireland or Luxembourg, so use Venue for UK ETFs.

Five rulebooks

RulebookVerdictHalalNot halalSplit (0–100%)
Akinda fund screen (AAOIFI)Not halal82.83%17.07%
DJIMNot halal83.29%13.31%
FTSENot halal40.84%55.76%
MSCINot halal40.84%55.76%
S&PNot halal83.29%10.40%

Every bar uses the same 0–100% scale. Index rulebooks report only halal and not-halal weight; uncoloured weight is weight that rulebook does not classify. Coverage is published for the Akinda fund screen only.

The fund screen and the four index rulebooks answer different questions, so they are expected to disagree. A fund can be doubtful on our fund screen and halal under S&P; both are correct.

Holdings

1–30 of 30 holdings, largest first · basket as of 30 Oct 2026
No.HoldingWeightAkinda (AAOIFI)DJIMFTSEMSCIS&P
1
GMABGenmab A/S (ADR)
4.82%HalalHalalNot halalNot halalHalal
2
HALOHalozyme Therapeutics, Inc.
3.76%Not halalHalalNot halalNot halalHalal
3
VCYTVeracyte, Inc.
3.65%HalalHalalHalalHalalHalal
4
ADMAADMA Biologics, Inc.
3.59%HalalHalalHalalHalalHalal
5
ALKSAlkermes Plc
3.53%HalalHalalNot halalNot halalHalal
6
AMGNAmgen Inc.
3.51%Not halalNot halalNot halalNot halalNot halal
7
BIIBBiogen Inc.
3.50%HalalHalalHalalHalalHalal
8
EXELExelixis, Inc.
3.50%HalalHalalNot halalNot halalHalal
9
NEONeoGenomics, Inc.
3.47%Not halalNot halalHalalHalalNot halal
10
REGNRegeneron Pharmaceuticals, Inc.
3.47%HalalHalalHalalHalalHalal
11
GILDGilead Sciences, Inc.
3.46%HalalHalalNot halalNot halalHalal
12
ARGXargenx SE (ADR)
3.44%HalalHalalNot halalNot halalHalal
13
NTRANatera, Inc.
3.44%HalalHalalNot halalNot halalHalal
14
RGENRepligen Corporation
3.43%HalalHalalHalalHalalHalal
15
UTHRUnited Therapeutics Corporation
3.42%Not halalNot halalNot halalNot halalNot halal
16
VRTXVertex Pharmaceuticals Incorporated
3.35%HalalHalalHalalHalalHalal
17
BRKRBruker Corporation
3.33%HalalHalalHalalHalalHalal
18
BMRNBioMarin Pharmaceutical Inc.
3.32%HalalHalalHalalHalalHalal
19
ONCBeiGene, Ltd. (ADR)
3.32%HalalHalalNot halalNot halalHalal
20
TGTXTG Therapeutics, Inc.
3.32%HalalHalalHalalHalalHalal
21
ILMNIllumina, Inc.
3.30%HalalNot ratedNot ratedNot ratedNot rated
22
INCYIncyte Corporation
3.27%HalalHalalNot halalNot halalHalal
23
NBIXNeurocrine Biosciences, Inc.
3.25%HalalHalalHalalHalalHalal
24
TARSTarsus Pharmaceuticals, Inc.
3.21%HalalHalalNot halalNot halalHalal
25
TECHBio-Techne Corporation
3.17%HalalHalalHalalHalalHalal
26
BNTXBioNTech SE (ADR)
2.91%Not halalNot halalNot halalNot halalNot rated
27
MDGLMadrigal Pharmaceuticals, Inc.
2.89%HalalHalalNot halalNot halalHalal
28
AXSMAxsome Therapeutics, Inc.
2.69%HalalHalalNot halalNot halalHalal
29
ALNYAlnylam Pharmaceuticals, Inc.
2.36%HalalHalalNot halalNot halalHalal
30
CORTCorcept Therapeutics Incorporated
2.24%HalalHalalNot halalNot halalHalal

Not rated means we hold no usable verdict for that company; it is never treated as compliant.

How Akinda screens funds and stocks